Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
PharmaKing
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients over 18, under 75 years of age
Patients with non-alcoholic fatty liver disease
You may not be if
Over 2 ratio of AST to ALT
Type 1 diabetes mellitus (insulin-dependent diabetes mellitus)
Disorder in liver function with an exception of non-alcoholic fatty liver (e.g. Virus infection, biliary atresia, autoimmune hepatitis and etc.)
Patients who have been taken drugs induced fatty liver for over 3 month within 1 year of participation in this study; amiodarone, tamoxifen, methotrexate, tetracyclines, glucocorticoids, anabolic steroids, over usual dose of estrogen for hormone replacement therapy and valproate
Patients who has been taken any medications that could affect the treatment for non-alcoholic steatohepatitis: insulin, insulin sensitizer(metformin, thiazolidinedione), high dose of vitamin E, high dose of UDCA, pentoxifylline, SAM-e, Betaine, types of Statin, types of fibrate and orlistat
Patients who had a Bariatric surgery less than 6 month prior to the participation in the study
Patients who are judged by investigator that participation of the study is difficult due to disease as follow; hepatic cirrhosis, Wilson's disease, malignant tumor, serious metabolic disease, severe renal disease, severe pulmonary disease, severe cardiovascular disease, severe nervous disease/psychiatric disorder, muscle disease and etc
Any history of immune disorder which affect the changes in cytokine:
inflammatory bowel disease, autoimmune thrombocytopenic purpura, system lupus erythematosus, autoimmune hemolytic anemia, severe psoriasis, rheumatic arthritis and etc
Patients who have received treatment that may affect liver function within 1 month prior to the participation in the study
Patient who has been administered other investigational product within 1 month prior to the participation in the study
Patient who is not allowed to get MRS test: pacemaker, shunt and etc
Pregnant or nursing women
Patient who considered ineligible for participation in the study as Investigator's judgment
Clareo Health | Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease
